AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
LONDON, GREATER LONDON, UK, September 6, 2023/EINPresswire.com/ -- The Business Research Company’s “Ankylosing Spondylitis Global Market Report 2023” is a comprehensive source of information that covers every facet of the market. As per TBRC’s market forecast, the ankylosing spondylitis market size is predicted to reach $7.29 billion in 2027 at a CAGR of 7.8%.
The growth in the ankylosing spondylitis market is due to the increasing geriatric population. North America region is expected to hold the largest ankylosing spondylitis market share. Major players in the ankylosing spondylitis market include Pfizer Inc., Johnson & Johnson Pvt. Ltd., Merck & Co. Inc., AbbVie Inc., Novartis AG, Bristol-Myers Squibb, Eli Lilly and Company, Gilead Sciences Inc.
Ankylosing Spondylitis Market Segments
• By Treatment Type: Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Anti-Rheumatic Drugs (DMARDS), Biological Therapies, Steroids, Physical Therapies, Surgery
• By Molecule: Biologics, Biosimilar, Small Molecules
• By Route of Administration: Parenteral, Oral, Other Routes
• By Application: Juveniles, Adults
• By End User: Hospitals, Clinics, Research Laboratories, Other End Users
• By Geography: The global ankylosing spondylitis market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Learn More On The Market By Requesting A Free Sample (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=11962&type=smp
Ankylosing spondylitis (AS) is a chronic inflammatory disease that primarily affects the spine and sacroiliac joints (the joints connecting the lower spine to the pelvis). It involves inflammation of the joints and entheses and affects joints, leading to pain, stiffness, and progressive loss of mobility in the spine.
Read More On The Ankylosing Spondylitis Global Market Report At:
https://www.thebusinessresearchcompany.com/report/ankylosing-spondylitis-global-market-report
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Ankylosing Spondylitis Market – Macro Economic Scenario
5. Ankylosing Spondylitis Market Size And Growth
……
27. Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Market
29. Market Future Outlook and Potential Analysis
30. Appendix
Browse Through More Similar Reports By The Business Research Company:
Arthritis Monoclonal Antibodies Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/arthritis-monoclonal-antibodie-global-market-report
TNF Alpha Inhibitors Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/tnf-alpha-inhibitor-global-market-report
Adalimumab, Infliximab And Etanercept Biosimilars Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/adalimumab-infliximab-and-etanercept-biosimilar-global-market-report
Contact Information
The Business Research Company: https://www.thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]
Check out our:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
Twitter
LinkedIn
